Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004)

International Journal of Antimicrobial Agents

Volumn 30, Issue 6, 2007, Pages 546-550

  Cantón, Rafael ^a   Unal, Serhat ^b   Farrell, David J ^c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HACETTEPE UNIVERSITY   (Turkey)

^c GR Micro Ltd   (United Kingdom)

Author keywords

Drug resistance, bacterial; Drug resistance, multiple; Geriatrics; Microbial sensitivity tests; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFUROXIME; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; TELITHROMYCIN; TETRACYCLINE;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; ERM GENE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEF GENE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 35748944530     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.07.025     Document Type: Article

References (17)

1. Guthrie R. Community-acquired lower respiratory tract infections: etiology and treatment. Chest 120 (2001) 2021-2034
2. Gutierrez F., Masia M., Mirete C., et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 53 (2006) 166-174
3. Niederman M.S., and Ahmed Q.A. Community-acquired pneumonia in elderly patients. Clin Geriatr Med 19 (2003) 101-120
4. Neralla S., and Meyer K.C. Drug treatment of pneumococcal pneumonia in the elderly. Drugs Aging 21 (2004) 851-864
5. Niederman M.S. Review of treatment guidelines for community-acquired pneumonia. Am J Med 117 Suppl. 3A (2004) 51S-57S
6. Woodhead M., Blasi F., Ewig S., et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26 (2005) 1138-1180
7. Fuller J.D., McGeer A., and Low D.E. Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management. Eur J Clin Microbiol Infect Dis 24 (2005) 780-788
8. Daneman N., McGeer A., Green K., and Low D.E. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 43 (2006) 432-438
9. File T.M. Telithromycin new product overview. J Allergy Clin Immunol 115 (2005) S1-S13
10. Felmingham D. The need for antimicrobial resistance surveillance. J Antimicrob Chemother 50 Suppl. S1 (2002) 1-7
11. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A7. Wayne, PA: CLSI; 2006.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. M100-S16. Wayne, PA: CLSI; 2006.
13. Shackcloth J., Williams L., and Farrell D.J. Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromycin versus comparators. J Infect 48 (2004) 229-235
14. Farrell D.J., Morrissey I., Bakker S., and Felmingham D. Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization. J Antimicrob Chemother 48 (2001) 541-544
15. Kyaw M.H., Lynfield R., Schaffner W., et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354 (2006) 1455-1463
16. Farrell D.J., Jenkins S.G., Brown S.D., Patel M., Lavin B.S., and Klugman K.P. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg Infect Dis 11 (2005) 851-858
17. Farrell D.J., Jenkins S.G., Patel M., and Lavin B. Antimicrobial resistance patterns among Streptococcus pneumoniae isolated from elderly patients: data from the PROTEKT US study years 1-4. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington, DC (2005)